Can-Fite Reports Second Quarter 2023 Financial Results & Pro

Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology, inflammatory and liver diseases, today announced financial results...

Related Keywords

Russia , Italy , Ukraine , United States , Israel , American , Russian , Pnina Fishman , Motti Farbstein , European Medicines Agency , American Society Of Clinical Oncology , Telethon Institute Of Genetics , Drug Administration , University Of Naples Federico , Fite Biopharma Ltd , Development For Treatment Of Lowe Syndrome , Data Monitoring Committee , Can Fite Biopharma , Liver Cancer Study , Independent Data Monitoring Committee , Abstract Award , Breakthrough Abstract Award , American Society , Clinical Oncology , Conquer Cancer Foundationfor , Cancer Study , Pancreatic Carcinoma , Pivotal Phase , Can Fite Received Green Light , Lowe Syndrome , Rare Genetic Disease , Naples Federico , Telethon Institute , Fondazione Telethon , Executive Chairman , Fite Biopharma , Orphan Drug Designation , Fast Track Designation , Annual Report , Markets ,